It was considered that disease mitigation by mitofusin activation in conditions such as SOD1 mutant ALS, which are not caused by a primary abnormality of mitofusins, might require sustained and continuous treatment to interrupt the postulated vicious cycle of mitochondrial degeneration. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.